Abstract:
A computer-implemented method for the simulation of myocardial blood flow under stress conditions comprises a step of generating a simulated multi-physics model of a myocardial perfusion, wherein the step of generating further comprises: a step of generating a simulated model of the epicardial vessels based on a three-dimensional fluid-dynamics description; a step of generating a simulated model of the intramural vessels based on a multi-compartment porous medium; a step of coupling the simulated model of the epicardial vessels and the simulated model of the intramural vessels; a step of automatic calibration of physical parameters of the simulated multi-physics model of a myocardial perfusion under stress conditions, wherein the calibrated physical parameters are permeability tensors, conductances between the epicardial coronary arteries and the intramural vessels, and inter-compartment conductances between the compartments.
Abstract:
Disclosed is a method for evaluating residual platelet thrombotic potential in patients undergoing antiplatelet treatment, which comprises determination in a patient's blood sample of vasodilator-stimulated phosphoprotein phosphorylation (VASP-P) status and platelet tissue factor (TF) expression.
Abstract:
A conditioning device for conditioning an exposed stretch of a blood vessel has an envelope and at least one conveying channel extending entirely within the envelope. The envelope has a first layer having a first surface facing the exposed stretch, and a second layer having a second surface, opposite to the first surface. The at least one conveying channel has at least one first aperture leading out of the envelope, so that the at least one conveying channel is suppliable with working fluid through the at least one first aperture. The first layer is permeable to at least one component of the working fluid, so that, when the working fluid is in the at least one conveying channel, the at least one component, permeating the first layer, diffuses until reaching the first surface to apply a conditioning action on the exposed stretch of the blood vessel.
Abstract:
Disclosed are compounds able to modulate the activity of the GPR17 receptor in a highly specific way, which are useful in the treatment and diagnosis of diseases or dysfunctions involving the activation of said receptor. In particular, the compounds according to the invention can be used for neuroprotective and/or reparatory purposes, in cerebral, cardiac and renal ischaemia, in cerebral trauma, in chronic neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), and in demyelinating diseases such as multiple sclerosis.